Edward G. Stopa, M.D.C.M., McGill University, 1980
Affiliations: | Pathology | Brown University, Providence, RI |
Area:
Aging and Alzheimer’s Disease; Circadian Rhythms, NeuroendocrinologyWebsite:
http://bms.brown.edu/pathology_residency/bios/stopa.htmlGoogle:
"Edward Stopa"Mean distance: 106866
Cross-listing: Alzheimer's Tree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kim B, De La Monte S, Hovanesian V, et al. (2019) Ontogeny of inter-alpha inhibitor protein (IAIP) expression in human brain. Journal of Neuroscience Research |
| Agca C, Klakotskaia D, Stopa EG, et al. (2019) Ovariectomy Influences Cognition and Markers of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad |
| Chen X, Nakada S, Donahue JE, et al. (2019) Neuroprotective effects of inter-alpha inhibitor proteins after hypoxic-ischemic brain injury in neonatal rats. Experimental Neurology |
| Kant S, Stopa EG, Johanson CE, et al. (2018) Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer's disease. Fluids and Barriers of the Cns. 15: 34 |
| Chen X, Zhang J, Kim B, et al. (2018) High-mobility group box-1 translocation and release after hypoxic ischemic brain injury in neonatal rats. Experimental Neurology |
| Ott BR, Jones RN, Daiello LA, et al. (2018) Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines. Frontiers in Aging Neuroscience. 10: 245 |
| Stopa EG, Tanis KQ, Miller MC, et al. (2018) Comparative transcriptomics of choroid plexus in Alzheimer's disease, frontotemporal dementia and Huntington's disease: implications for CSF homeostasis. Fluids and Barriers of the Cns. 15: 18 |
| Klakotskaia D, Agca C, Richardson RA, et al. (2018) Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease. Plos One. 13: e0195469 |
| Steeland S, Gorlé N, Vandendriessche C, et al. (2018) Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer's disease. Embo Molecular Medicine. 10 |
| Johansona CE, Stopa EG, Daiello L, et al. (2018) Disrupted Blood-CSF Barrier to Urea and Creatinine in Mild Cognitive Impairment and Alzheimer's Disease Journal of Alzheimers Disease & Parkinsonism. 8: 1-7 |